References
- Anderson, S.A. and Raiten, D.J. (1992) “Safety of amino acids used as dietary supplements”, Life Science Research Office (FASEB Special Publications Office, Bethesda).
- Blanchard, R.J., Yudko, E.B., Rodgers, R.J. and Blanchard, D.C. (1993 ) “Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety”, Behavioral Brain Research 58, 155–165.
- Chang, Y.F., Wing, Y., Cauley, R.K. and Gao, X.M. (1993 ) “Chronic L-lysine develops anti-pentylenetetrazol tolerance and reduces synaptic GABAergic sensitivity”, European Journal of Pharmacology 233, 209–217.
- Dunn, J., Rees, H.D. and Iuvone, P.M. (1978 ) “ACTH and stress- induced changes of lysine incorporation into brain and liver proteins”, Pharmacology, Biochemistry and Behavior 8, 455–465.
- Flodin, N.W. (1997 ) “The metabolic roles, pharmacology and toxicology of lysine”, Journal of American College of Nutrition 16, 7–21.
- Gietzen, D.W., Erecius, L.F. and Rogers, Q.R. (1998 ) “Neurochemical changes after imbalanced diets suggest a brain circuit mediating anorectic responses to amino acid deficiency in rats”, Journal of Nutrition 128, 771–781.
- Guan, H.P. and Ku, B.S. (1999) “Neuroprotective effect of L-lysine HCl on acute iterative anoxia in rats with quantitative analysis of electrocorticogram”, Life Science 65, PL19–PL25.
- Hogg, S. (1996 ) “A review of the validity and variability of the elevated plus-maze as an animal model of anxiety”, Pharmacology, Biochemistry and Behavior 54, 21–30.
- Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshelman, S., Willchen, H.U. and Kendler, K.S. (1994 ) “Lifetime and 12-month prevalence of DSM–III–R psychiatric disorders in the United States”, Archives of General Psychology 51, 8–19.
- Obled, C., Papet, I. and Breuille, D. (2000 ) “Metabolic bases of amino acid requirements in acute diseases”, Current Opinions in Clinical and Nutritional Metabolism Care 5, 189–197.
- Pshenikova, M.G., Bondarenko, N.A. and Shimkovich, M.V. (2001 ) “Nitric oxide as a factor of genetically determined resistance to stress damage and adaptive protection”, Bulletin of Experimental and Biological Medicine 132, 1048–1050.
- Rivier, C. (2001 ) “Role of gaseous neurotransmitters in the hypothalamic-pituitary adrenal axis”, Annals of New York Academy of Sciences 933, 254–264.
- Rodgers, R.J., Haller, J., Holmes, A., Halasz, J., Walton, T.J. and Brain, P.F. (1999 ) “Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice”, Physiology and Behavior 68, 47–53.
- Smith, J. and Kowles, J. (2000 ) “Behaviour in early treated phenylketonuria: a systematic review”, European Journal of Pediatrics 159, S89–S93.
- Smriga, M., Mori, M. and Torii, K. (2000 ) “Circadian release of hypothalamic norepinephrine in rats in vivo is depressed during early L-lysine deficiency”, Journal of Nutrition 130, 1641–1643.
- Smriga, M., Kameishi, M., Uneyama, H. and Torii, K. (2002 ) “Deficiency of dietary L-lysine increases stress-induced anxiety and fecal excretion in rats”, Journal of Nutrition 132, 3744–3746.